Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Robert Michael Saller"'
Autor:
Michael Schrewe, Matthias Löhr, Oliver V. Fabian, Robert Michael Saller, Eduard Ryschich, Walter Harms, Ralf Jesnowski, Jan Schmidt, Jörg Ringel, Alexander Engel
Publikováno v:
International Journal of Cancer. 113:649-653
Local therapy of pancreatic cancer with microencapsulated CYP2B1-producing cells and ifosfamide showed an effect both on the primary tumor and on distant metastatases. This possibly represents a consequence of the activation of immune response. Other
Autor:
Zbigniew Gradski, Heinrich Prosl, Brian Salmons, Matthias Renner, Robert Michael Saller, Stanisław Winiarczyk, Cornelia Gabler, Barbara Kosztolich, Gerhardt König, Walter H. Günzburg, Johannes Hain
Publikováno v:
Journal of Molecular Medicine. 80:610-614
Autor:
Giovanni Esposito, Steffen Mitzner, Stefano Indraccolo, Alberto Amadori, Vincenzo Coppola, Robert Michael Saller, Walter H. Günzburg, Jan Stange, Brian Salmons
Publikováno v:
The Journal of Gene Medicine. 4:150-160
Background Because gene therapy of the future will primarily take an in vivo approach, a number of problems associated with its current implementation exist. Currently, repeated delivery of a vector in vivo is necessary to ensure adequate transfer of
Autor:
Thomas Kammertoens, Robert Michael Saller, Klemens Alton, Wolfgang Gelbmann, Brian Salmons, Wolfgang Uckert, Peter Karle, Walter H. Günzburg
Publikováno v:
Cancer Gene Therapy. 7:629-636
The success of chemotherapeutic intervention is limited because the necessary high local drug doses cannot be achieved without systemic toxicity. Application of suicide genes (SGs) and direct conversion of prodrugs (PDs) to toxic metabolites in situ
Autor:
Hartmut Stein, Peter Karle, Horst Nizze, Brian Salmons, Stefan Liebe, Thomas E. Wagner, Matthias Löhr, Walter H. Günzburg, Katrin Püschel, Petra Müller, Kerstin von Rombs, Regina Renz, Ralf Jesnowski, Robert Michael Saller
Publikováno v:
Karolinska Institutet
The prognosis of pancreatic cancer is poor, and current medical treatment is mostly ineffective. The aim of this study was to design a new treatment modality in an animal model system. We describe here a novel treatment strategy employing a mouse mod
Autor:
Gerd Grasnick, Horst Dr Dautzenberg, Peter Karle, Matthias Löhr, Mireia Pelegrin, Kerstin von Rombs, Brian Salmons, Robert Michael Saller, Petra Müller, Walter H. Günzburg, Marc Piechaczyk, Ute Schuldt
Publikováno v:
Karolinska Institutet
Microencapsulation, as a tool for immunoisolation for allogenic or xenogenic implants, is a rapidly growing field. However most of the approaches are based on alginate/polylysine capsules, despite this system's obvious disadvantages such as its pyrog
Publikováno v:
Journal of Virology. 72:1699-1703
Mouse mammary tumor virus (MMTV)-based vectors are characterized by low titers. In an effort to transfer MMTV-specific regulation of gene expression to a more efficient murine leukemia virus (MLV) vector, we have replaced the complete 3′ U3 region
Autor:
Michael Keese, R Prosst, Jörg W Sturm, S. Samel, M. Hafner, Robert Michael Saller, A Lux, Ralf Jesnowski, Stefan Post, Matthias Löhr
Publikováno v:
Cancer gene therapy. 13(1)
The prognosis of peritoneal spread from gastrointestinal cancer and subsequent malignant ascites is poor, and current medical treatments available are mostly ineffective. Targeted chemotherapy with intraperitoneal prodrug activation may be a benefici
Autor:
Johannes Hain, Matthias Löhr, Brian Salmons, Jörg Ringel, Grit Faulmann, Frank Hummel, Walter H. Günzburg, Robert Michael Saller
Publikováno v:
Cancer chemotherapy and pharmacology. 49
Background. Conventional chemotherapy of pancreatic carcinoma is only marginally effective. This is in part due to the severity of side effects following systemic administration of the cytostatic drug. The aim was to create a therapeutic tool allowin
Autor:
Reiko Wiessner, Karlheinz Hauenstein, Günter Klöppel, Kerstin von Rombs, Ilse Schwendenwein, Matthias Löhr, Robert Michael Saller, Helga Bergmeister, Peter Karle, Walter H. Günzburg, Robert Obermaier, Matthias Renner, A. Probst, Petra Müller, Udo Losert, Horst Nizze, Brian Salmons, Jens-Christian Kröger, Anne Hoffmeyer, Thomas E. Wagner, Zoltan Bago, Stefan Benz
Publikováno v:
Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]. 3(1)
Background: The therapeutic efficacy of intratumoral instillation of genetically engineered, CYP2B1-expressing, microencapsulated cells in combination with ifosfamide had been previously demonstrated in xenografted human pancreatic ductal carcinomas